Prudential Financial’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Prudential Financial’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-20,440	Closed	-$46.6K	–	2821
2024 Q2	$46.6K	Buy	20,440 +4,840	+31%	+$18.5K	﹤0.01%	2617
2024 Q1	$67.4K	Sell	15,600 -2,800	-15%	-$9.76K	﹤0.01%	2568
2023 Q4	$56.1K	Sell	18,400 -2,600	-12%	-$4.88K	﹤0.01%	2542
2023 Q3	$30.2K	Buy	21,000 +4,800	+30%	+$9.29K	﹤0.01%	2547
2023 Q2	$40.3K	Buy	+16,200	New	+$44.3K	﹤0.01%	2554

Prudential Financial's GTHX Position: Q3 2024 in Review

Prudential Financial sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2024, closing a stake of 20,440 shares — an estimated $46.6K sold.

Prudential Financial first reported a position in GTHX in Q2 2023 and held it in 5 quarters. The position peaked at $67.4K in Q1 2024. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.

Prudential Financial reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Prudential Financial sold 20,440 G1 Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $46.6K.
Prudential Financial first reported a position in G1 Therapeutics, Inc. Common Stock in Q2 2023 and held it in 5 quarters.
Prudential Financial's G1 Therapeutics, Inc. Common Stock position peaked at $67.4K in Q1 2024.
0 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Prudential Financial's 13F filing for Q3 2024, filed 14 Nov 2024.